Cargando…
PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311565/ http://dx.doi.org/10.1016/j.annonc.2021.05.557 |
_version_ | 1783728983619141632 |
---|---|
author | Shibata, Takashi Ishimabushi, Yuki Suzuki, Masato Uchida, Toshiki Sakamoto, Eiji Ogasawara, Tomohiko Yamamuro, Osamu |
author_facet | Shibata, Takashi Ishimabushi, Yuki Suzuki, Masato Uchida, Toshiki Sakamoto, Eiji Ogasawara, Tomohiko Yamamuro, Osamu |
author_sort | Shibata, Takashi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8311565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83115652021-07-26 PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center Shibata, Takashi Ishimabushi, Yuki Suzuki, Masato Uchida, Toshiki Sakamoto, Eiji Ogasawara, Tomohiko Yamamuro, Osamu Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-07 2021-07-26 /pmc/articles/PMC8311565/ http://dx.doi.org/10.1016/j.annonc.2021.05.557 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Shibata, Takashi Ishimabushi, Yuki Suzuki, Masato Uchida, Toshiki Sakamoto, Eiji Ogasawara, Tomohiko Yamamuro, Osamu PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
title | PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
title_full | PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
title_fullStr | PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
title_full_unstemmed | PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
title_short | PD4-1-3 A result of questionnaire about COVID-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
title_sort | pd4-1-3 a result of questionnaire about covid-19 and chemotherapy, for patients utilizing outpatient chemotherapy center |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311565/ http://dx.doi.org/10.1016/j.annonc.2021.05.557 |
work_keys_str_mv | AT shibatatakashi pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter AT ishimabushiyuki pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter AT suzukimasato pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter AT uchidatoshiki pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter AT sakamotoeiji pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter AT ogasawaratomohiko pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter AT yamamuroosamu pd413aresultofquestionnaireaboutcovid19andchemotherapyforpatientsutilizingoutpatientchemotherapycenter |